Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics

(2014) Bjoern Moosmann et al.   Drug Testing and Analysis

Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products

(2014) Nahoko Uchiyama et al.   Forensic Toxicology

A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization

(2014) Laura M. Huppertz et al.   JOURNAL OF MASS SPECTROMETRY

Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

(2013) Bjoern Moosmann et al.   Forensic Toxicology

Rapid and simultaneous extraction of acidic and basic drugs from human whole blood for reliable semi-quantitative NAGINATA drug screening by GC–MS

(2013) Keiko Kudo et al.   Forensic Toxicology

Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics

(2013) Bjoern Moosmann et al.   JOURNAL OF MASS SPECTROMETRY

Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use

(2009) Rashad A. Abdul-Ghani et al.   PARASITOLOGY RESEARCH

Case report: Etizolam and its major metabolites in two unnatural death cases

(2008) Takuma Nakamae et al.   FORENSIC SCIENCE INTERNATIONAL